Chemokines and central nervous system disorders

Journal of NeuroVirology

Volumn 7, Issue 6, 2001, Pages 493-500

  Karpus, W J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Central nervous system; Chemokine receptors; Chemokines; Demyelinating disease

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CX3C CHEMOKINE;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANIMAL CELL; BACTERIAL INFECTION; BIOACCUMULATION; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATING DISEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; LEUKOCYTE; LEUKOCYTE ACTIVATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINES; ENCEPHALITIS, VIRAL; HUMANS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0035669481     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/135502801753248079     Document Type: Review

References (70)

1. C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system
2. + T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
3. A new class of membrane-bound chemokine with a CX3C motif
4. The CCR5 deletion mutation fails to protect against multiple sclerosis
5. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: Implications for establishment of a Th1/Th2 bias
6. Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1
7. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties
8. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis
9. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model
10. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
11. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
12. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
13. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
14. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
15. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis
16. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis
17. Chemokine expression in murine experimental allergic encephalomyelitis
18. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
19. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo
20. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor
21. Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease
22. Expression of chemokine receptors by subsets of neurons in the central nervous system
23. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
24. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis
25. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions
26. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis
27. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced
28. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
29. Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
30. Pathways to neuronal injury and apoptosis in HIV-associated dementia
31. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
32. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1
33. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses
34. Chemokines and chemotaxis of leukocytes in infectious meningitis
35. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease
36. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination
37. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1
38. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
39. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system
40. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease
41. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein
42. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study
43. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]
44. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
45. Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases
46. CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2
47. International union of pharmacology. XXII. Nomenclature for chemokine receptors
48. Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis
49. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis
50. Experimental autoimmune encephalomyelitis on the SJL mouse: Effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system
51. Chemokine receptor antagonism as a new therapy for multiple sclerosis
52. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
53. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
54. Biology of the RANTES/SIS cytokine family
55. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
56. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
57. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
58. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions
59. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
60. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
61. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes
62. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β
63. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor
64. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions
65. Chemokines: Understanding their role in T-lymphocyte biology
66. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
67. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains
68. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta
69. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia
70. Chemokines: A new classification system and their role in immunity